ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms

Authors

• Hassan Awada, Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• Manasa Bhatta, Department of Medicine, The Mount Sinai Hospital, New York, NY, USA.
• Han Yu, Department of Biostatistics & Bioinformatic, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• Wenyan Ji, Virginia Polytechnic Institute and State University, Center for Biostatistics and Health Data Science, Blacksburg, VA, USA.
• Surui Hou, Department of Biostatistics & Bioinformatic, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• Tara Cronin, Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• Sheeba Ba Aqeel, Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• Arya Mariam Roy, Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• Muhammad Salman Faisal, Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• Peter Kouides, Rochester Regional HealthFollow
• John Mascarenhas, Tisch Cancer Institute, Division of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
• Elizabeth A. Griffiths, Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.
• Amro Elshoury, Benign Hematology & Leukemia Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Department

Oncology and Hematology

Document Type

Article

Publication Title

Leukemia

First Page

210

Last Page

214

DOI

10.1038/s41375-023-02069-7

Volume

38

Issue

1

Publication Date

1-1-2024

Medical Subject Headings

Humans; Neoplasms; Myeloproliferative Disorders (genetics); Philadelphia Chromosome; Mutation; Repressor Proteins (genetics)

PubMed ID

37919607

Recommended Citation

Awada, H., Bhatta, M., Yu, H., Ji, W., Hou, S., Cronin, T., Ba Aqeel, S., Roy, A. M., Faisal, M. S., Kouides, P., Mascarenhas, J., Griffiths, E. A., & Elshoury, A. (2024). ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms. Leukemia, 38 (1), 210-214. https://doi.org/10.1038/s41375-023-02069-7